+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations

Journal of Bone and Mineral Research 27(2): 342-351

Autosomal recessive osteopetrosis (ARO) is a genetically heterogeneous disorder attributed to reduced bone resorption by osteoclasts. Most human AROs are classified as osteoclast rich, but recently two subsets of osteoclast-poor ARO have been recognized as caused by defects in either TNFSF11 or TNFRSF11A genes, coding the RANKL and RANK proteins, respectively. The RANKL/RANK axis drives osteoclast differentiation and also plays a role in the immune system. In fact, we have recently reported that mutations in the TNFRSF11A gene lead to osteoclast-poor osteopetrosis associated with hypogammaglobulinemia. Here we present the characterization of five additional unpublished patients from four unrelated families in which we found five novel mutations in the TNFRSF11A gene, including two missense and two nonsense mutations and a single-nucleotide insertion. Immunological investigation in three of them showed that the previously described defect in the B cell compartment was present only in some patients and that its severity seemed to increase with age and the progression of the disease. HSCT performed in all five patients almost completely cured the disease even when carried out in late infancy. Hypercalcemia was the most important posttransplant complication. Overall, our results further underline the heterogeneity of human ARO also deriving from the interplay between bone and the immune system, and highlight the prognostic and therapeutic implications of the molecular diagnosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333144

Download citation: RISBibTeXText

PMID: 22271396

DOI: 10.1002/jbmr.559

Related references

RANK-dependent autosomal recessive osteopetrosis characterisation of 5 new cases with novel mutations. 2011

Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients. Osteoporosis International 27(3): 1047-1055, 2015

Genotype-phenotype relationship in human autosomal recessive osteopetrosis dependent on mutations of the ATP6i gene. Journal of Bone & Mineral Research 17(Suppl 1): S382, September, 2002

Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank. Journal of Bone and Mineral Research 19(10): 1689-1697, 2004

Novel mutations in Indian patients with autosomal recessive infantile malignant osteopetrosis. Indian Journal of Medical Research 131(): 508-514, 2010

Identification of TCIRG1 and CLCN7 gene mutations in a patient with autosomal recessive osteopetrosis. Molecular Medicine Reports 9(4): 1191-1196, 2014

Autosomal recessive osteopetrosis: report of 41 novel mutations in the TCIRG1 gene and diagnostic implications. Osteoporosis International 23(11): 2713-2718, 2013

Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Human Genetics 112(2): 186-189, 2003

Buried in the Middle but Guilty: Intronic Mutations in the TCIRG1 Gene Cause Human Autosomal Recessive Osteopetrosis. Journal of Bone and Mineral Research 30(10): 1814-1821, 2016

SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity. Journal of Bone and Mineral Research 28(5): 1041-1049, 2013

Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. Journal of Bone and Mineral Research 21(7): 1098-1105, 2006

Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. American Journal of Pathology 162(1): 57-68, 2003

Mild osteopetrosis in the microphthalmia-oak ridge mouse. A model for intermediate autosomal recessive osteopetrosis in humans. American Journal of Pathology 147(6): 1871-1882, 1995

GTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: identification and functional characterization of four novel mutations. Journal of Inherited Metabolic Disease 27(4): 455-463, 2004

Characterization of mutations in the chloride channel 7 gene that cause autosomal dominant osteopetrosis, Type II. Journal of Bone & Mineral Research 17(Suppl 1): S144-S145, September, 2002